Werewolf Therapeutics (HOWL) Assets

Price: $0.8907
Market Cap: $39.93M
Avg Volume: 257.56K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.484
52W Range: $0.595-6.89
Website: Werewolf Therapeutics

Werewolf Therapeutics Asset Metrics Summary

According to Werewolf Therapeutics's latest annual financial reports, the company's asset profile is as follows:

Total Assets

Werewolf Therapeutics's total assets amount to $126.93M. This is divided into:

  • Total Current Assets: $113.07M
  • Total Non-current Assets: $13.86M
  • Net Receivables: $-
  • Inventory: $-
  • Cash and Short-term Investments: $112.22M
  • Property, Plant, and Equipment (Net): $12.32M
  • Long-term Investments: $-
  • Goodwill and Intangible Assets: $-

Asset Ratios and Metrics

To better understand Werewolf Therapeutics's asset management, we can look at several key ratios:

  • Return on Assets (ROA): -55.55% - this indicates how profitable a company is relative to its total assets.
  • Asset Turnover: 0.01 - this shows how efficiently a company uses its assets to generate sales.
  • Current Ratio: 7.45 - this measures a company's ability to pay short-term obligations with its current assets.
  • Quick Ratio: 7.45 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
  • Cash Ratio: 7.39 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.

These metrics provide insight into Werewolf Therapeutics's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.

Total Assets

$126.93M

Total Current Assets

$113.07M

Total Non-current Assets

$13.86M

Net Receivables

$-

Inventory

$-

Cash and Short-term Investments

$112.22M

Property, Plant, and Equipment (Net)

$12.32M

Long-term Investments

$-

Goodwill and Intangible Assets

$-

Return on Assets

-55.55%

Asset Turnover

0.01

Current Ratio

7.45

Werewolf Therapeutics Historical Asset Metrics
Total Assets
Total Current Assets
Total Non-current Assets
$200.00M$200.00M$150.00M$150.00M$100.00M$100.00M$50.00M$50.00M$0.00$0.00Asset Metrics2020202020212021202220222023202320242024
Historical Return on Assets
11.11%11.11%-0.00%-0.00%-11.11%-11.11%-22.22%-22.22%-33.33%-33.33%-44.44%-44.44%-55.55%-55.55%Return on Assets202020202021202120222022202320232024202420252025
Historical Total Assets Growth
400.00%400.00%300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%Total Assets Growth202020202021202120222022202320232024202420252025

Werewolf Therapeutics Historical Assets

The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2024.

Year Total Assets Total Current Assets Total Non-current Assets Net Receivables Inventory Cash and Short-term Investments Property, Plant, Equipment (Net) Long-term Investments Goodwill and Intangible Assets Return on Assets Asset Turnover Current Ratio Quick Ratio Cash Ratio
2024 $126.93M $113.07M $13.86M $- $- $112.22M $12.32M $- $- -0.56 0.01 7.45 7.45 7.39
2023 $174.83M $138.37M $36.46M $1.35M $- $134.34M $14.85M $- $- -0.21 0.11 7.14 7.14 6.93
2022 $160.25M $140.20M $20.05M $6.93M $2 $129.31M $17.45M $1.21M $- -0.32 0.10 5.84 5.84 5.39
2021 $179.25M $161.07M $18.18M $- $- $157.53M $16.32M $1.21M $- -0.28 0.00 13.56 13.56 13.27
2020 $96.40M $92.91M $3.48M $- $- $92.57M $3.12M $207.00K $- -0.15 0.00 17.58 17.58 17.52
2019 $21.68M $18.06M $3.62M $- $- $17.90M $3.41M $208.00K $- -0.51 0.00 8.84 8.84 8.76

Related Metrics

Explore detailed financial metrics and analysis for HOWL.